Initial Treatment Approach for Hypertensive Patients
For newly diagnosed hypertensive patients, initiate immediate combination therapy with two antihypertensive medications as a single-pill combination if blood pressure is ≥150/90 mmHg, while patients with BP 130-150/80-90 mmHg should start with one medication alongside mandatory lifestyle modifications. 1, 2
Diagnostic Confirmation Required First
Before initiating treatment, confirm the diagnosis properly:
- Measure BP with a validated automated upper arm cuff device using appropriate cuff size, checking both arms and using the higher reading 2, 3
- Office BP ≥140/90 mmHg defines hypertension but must be confirmed with home BP monitoring (≥135/85 mmHg) or 24-hour ambulatory monitoring (≥130/80 mmHg) 1, 2, 3
- Assess for target organ damage, cardiovascular risk factors, diabetes, chronic kidney disease, and secondary causes 2, 3
Treatment Algorithm by Blood Pressure Level
BP 130/80 to 150/90 mmHg
- Start with monotherapy using one first-line agent 1
- Initiate immediate drug therapy if high cardiovascular risk is present (established CVD, CKD, diabetes, target organ damage, or age 50-80 years) 3
- First-line options include ACE inhibitors (lisinopril 10 mg daily), ARBs (losartan 50 mg daily), thiazide-like diuretics, or dihydropyridine calcium channel blockers 1, 4, 5
BP ≥150/90 mmHg
- Initiate two-drug combination therapy immediately, preferably as a single-pill combination 1, 2, 3
- For non-Black patients: ACE inhibitor or ARB + dihydropyridine calcium channel blocker 2, 3
- For Black patients: ARB + dihydropyridine calcium channel blocker OR calcium channel blocker + thiazide-like diuretic 2, 3
This immediate combination approach is critical—avoid clinical inertia, as combination therapy is more effective than sequential monotherapy titration. 2
Mandatory Lifestyle Modifications for All Patients
Lifestyle changes must be implemented for every patient with BP >120/80 mmHg, not discontinued once drug therapy starts: 1, 2
- DASH or Mediterranean diet with sodium restriction (<2.3 g/day) and increased potassium intake 1, 2, 3
- Weight reduction targeting BMI 20-25 kg/m² for overweight patients 1, 3
- Physical activity: minimum 150 minutes of moderate-intensity aerobic exercise weekly plus resistance training 2-3 times per week 1, 2, 3
- Alcohol moderation: maximum 2 units/day for men, 1 unit/day for women (or <100g/week total) 1, 3
- Complete smoking cessation 1, 3
These modifications are additive with pharmacologic therapy and may reduce medication requirements. 6, 7
Blood Pressure Targets
- Adults <65 years: <130/80 mmHg 1, 2
- Adults 65-85 years: systolic 120-129 mmHg if well tolerated 1, 3
- Adults >85 years: systolic 130-139 mmHg if well tolerated 1, 3
- Initial goal is to reduce BP by at least 20/10 mmHg 2
Titration and Monitoring Schedule
- Titrate antihypertensive dosages every 2-4 weeks until target BP is reached 1
- Schedule follow-up within 2-4 weeks initially to assess response and tolerability 2
- Achieve target BP within 3 months of initiating treatment 2, 3
- Monthly visits are recommended until BP target is achieved 1, 3
- Check serum creatinine and potassium 7-14 days after starting or adjusting ACE inhibitors, ARBs, or mineralocorticoid receptor antagonists 1, 2, 3
Escalation Strategy if Target Not Achieved
- If BP not controlled with two-drug combination, increase to three-drug combination (RAS blocker + dihydropyridine CCB + thiazide/thiazide-like diuretic) 3
- If still uncontrolled, add spironolactone as fourth agent 3
Critical Pitfalls to Avoid
- Never combine two RAS blockers (ACE inhibitor + ARB)—this is potentially harmful 1, 2, 3
- Avoid ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, direct renin inhibitors, and neprilysin inhibitors in sexually active women of childbearing age without reliable contraception; these are contraindicated in pregnancy 1
- Do not use immediate-release nifedipine for hypertension management 8
- Avoid starting with 50 mg losartan in patients with possible intravascular depletion (e.g., on diuretics)—use 25 mg instead 5
- Continue antihypertensive therapy lifelong, even beyond 85 years of age if well tolerated 1, 3